$41.74
0.88% today
Nasdaq, Feb 28, 05:19 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$42.11
-4.87 10.37% 1M
+15.96 61.03% 6M
+11.56 37.84% YTD
+22.58 115.62% 1Y
-24.16 36.46% 3Y
-35.05 45.43% 5Y
+9.91 30.78% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-1.08 2.50%
ISIN
US40131M1099
Symbol
GH
Sector

Key metrics

Market capitalization $5.20b
Enterprise Value $5.69b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 7.70
P/S ratio (TTM) P/S ratio 7.03
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 31.04%
Revenue (TTM) Revenue $739.02m
EBIT (operating result TTM) EBIT $-443.59m
Free Cash Flow (TTM) Free Cash Flow $-274.94m
Cash position $839.98m
EPS (TTM) EPS $-3.56
P/E forward negative
P/S forward 6.08
EV/Sales forward 6.66
Short interest 4.87%
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Guardant Health, Inc. forecast:

21x Buy
88%
2x Hold
8%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Guardant Health, Inc. forecast:

Buy
88%
Hold
8%
Sell
4%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
739 739
31% 31%
100%
- Direct Costs 290 290
27% 27%
39%
449 449
34% 34%
61%
- Selling and Administrative Expenses 503 503
2% 2%
68%
- Research and Development Expense 348 348
5% 5%
47%
-401 -401
23% 23%
-54%
- Depreciation and Amortization 42 42
1% 1%
6%
EBIT (Operating Income) EBIT -444 -444
21% 21%
-60%
Net Profit -436 -436
9% 9%
-59%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Neutral
Business Wire
one day ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of the second annual “Closing the Gap: CRC Screening Insights” survey, which showed that nine out of ten physicians surveyed are concerned about the percentage of their patients who do not complete colorectal cancer (CRC) screening. In many cases, this is due...
Neutral
Seeking Alpha
8 days ago
Call Start: 16:30 January 1, 0000 5:31 PM ET Guardant Health, Inc. (NASDAQ:GH ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Zarak Khurshid - Vice President, IR Helmy Eltoukhy - Co-Chief Executive Officer AmirAli Talasaz - Co-Chief Executive Officer Mike Bell - Chief Financial Officer Conference Call Participants Puneet Souda - Leerink Partners Bill Bonello...
Positive
The Motley Fool
8 days ago
Guardant Health (GH -3.26%), a leader in precision oncology testing, announced its fourth-quarter results on Feb. 20. Total revenue rose 30% year over year to $201.8 million, outpacing analysts' consensus estimates of $192 million.
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,021
Founded 2012
Website www.guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today